To satisfy the needs of pharmaceuticals companies pursuing rationalization of the drug-making process, we engage in the contract manufacture of intermediates, APIs, and formulations used in the research and developmemt of new drugs.
Nagase is actively developing optically active materials business. It successfully commercialized Prof. Maruoka's Asymmetric Phase Transfer Catalysts for industrial applications such as unique unnatural amino acids and derivatives thereof.